Global stocks of cholera vaccines have been exhausted, and any outbreak of the disease will put additional strain on the fragile production system of vaccination drugs. This is stated in a joint article by Tedros Adanom Ghebreyesus, Director General of the World Health Organization (WHO), and Hakainde Hichilema, President of Zambia.
Coronavirus vaccines slightly increase the risk of neurological and cardiovascular diseases. These are the conclusions reached by the Global Vaccine Data Network research centers.
The world's first registered vaccine against the coronavirus "Sputnik V" with the appearance of the COVID-19 strain "kraken" ceased to protect at all. Clinical trials of the updated vaccine are underway now. This was stated by the head of the Gamalei Center (the developer of Sputnik V), Alexander Ginzburg.
The Australian biotech company Vaxxas has created the first patch with a protein vaccine against coronavirus. According to The Australian newspaper, scientists have already managed to prove its high efficiency and ability to resist all major strains of SARS-CoV-2.
Scientists from the Ministry of Innovative Development of the Republic of Uzbekistan were able to obtain milk with antibodies to SARS-CoV-2 by vaccinating cows and goats against coronavirus. The researchers hope that the use of such milk will at least partially protect the population from COVID-19.
On January 7 of this year, the omicron strain was detected in the laboratory of the Center for Advanced Technologies (CLT) under the Ministry of Innovative Development.
According to the Embassy of our country in London, since January 10 of this year, the UK officially recognizes certificates of vaccination against coronavirus issued in Uzbekistan.
As previously reported, the first batch of the Sputnik V vaccine was delivered to Uzbekistan.
UNICEF is leading efforts to procure and supply COVID-19 vaccines in what could possibly be the world’s largest and fastest ever procurement and supply of vaccines, as part of the global vaccine plan of the COVID-19 Vaccine Global Access Facility (COVAX Facility) led by Gavi, the Vaccine Alliance.
